LENZ vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 25, 2026

LENZ

41.6
AI Score
VS
CBIO Wins

CBIO

50.1
AI Score

Investment Advisor Scores

LENZ

42score
Recommendation
HOLD

CBIO

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LENZ CBIO Winner
Revenue 1.90M 1.04M LENZ
Net Income -41.49M -23.28M CBIO
Net Margin -2182.4% -2240.9% LENZ
Operating Income -44.13M -24.73M CBIO
ROE -16.8% -12.7% CBIO
ROA -15.2% -11.7% CBIO
Total Assets 272.54M 199.13M LENZ
Cash 24.77M 189.16M CBIO
Current Ratio 10.40 13.78 CBIO
Free Cash Flow -33.60M -9.08M CBIO

Relative Price Performance (Last 90 Days)

LENZ 1M: -15.2% · 3M: -43.8% CBIO 1M: -13.0% · 3M: -17.7%

Current Technical Phase

LENZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.7%), weak momentum, RSI 39

RSI (14): 39.3 · Price: $5.00

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $14.87

Fundamentals Snapshot

Metric LENZ CBIO
Market Cap
Forward P/E -1.6 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.9% 1.0%
Operating Margin -23.2% -14.3%
EPS -3.53 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.